Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulosclerosis, Focal Segmental | 9 | 2020 | 43 | 1.410 |
Why?
|
| Zenker Diverticulum | 6 | 2025 | 12 | 1.220 |
Why?
|
| Mycophenolic Acid | 6 | 2020 | 120 | 0.650 |
Why?
|
| Dexamethasone | 5 | 2020 | 372 | 0.560 |
Why?
|
| Immunosuppressive Agents | 5 | 2020 | 847 | 0.450 |
Why?
|
| Proteinuria | 4 | 2020 | 102 | 0.280 |
Why?
|
| Prospective Studies | 11 | 2025 | 7997 | 0.230 |
Why?
|
| Cyclosporine | 3 | 2020 | 265 | 0.200 |
Why?
|
| Deglutition Disorders | 1 | 2025 | 147 | 0.200 |
Why?
|
| Diverticulum, Esophageal | 1 | 2022 | 4 | 0.190 |
Why?
|
| Diverticulum | 1 | 2022 | 14 | 0.190 |
Why?
|
| Pharyngeal Diseases | 1 | 2022 | 16 | 0.190 |
Why?
|
| Nephrotic Syndrome | 1 | 2023 | 44 | 0.190 |
Why?
|
| Esophageal Diseases | 1 | 2022 | 30 | 0.180 |
Why?
|
| Nephrology | 1 | 2023 | 60 | 0.180 |
Why?
|
| Muscular Diseases | 1 | 2022 | 108 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2023 | 288 | 0.170 |
Why?
|
| Glomerular Filtration Rate | 3 | 2020 | 760 | 0.160 |
Why?
|
| Drug Therapy, Combination | 3 | 2012 | 1048 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2023 | 427 | 0.140 |
Why?
|
| Quality of Life | 1 | 2010 | 3192 | 0.140 |
Why?
|
| Community Health Centers | 1 | 2018 | 59 | 0.130 |
Why?
|
| Length of Stay | 1 | 2023 | 1337 | 0.130 |
Why?
|
| Treatment Outcome | 8 | 2025 | 11695 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 2 | 2020 | 598 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2020 | 535 | 0.120 |
Why?
|
| Cyclosporins | 1 | 2015 | 71 | 0.110 |
Why?
|
| Pharyngeal Muscles | 2 | 2025 | 5 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2015 | 38 | 0.110 |
Why?
|
| Health Education | 1 | 2018 | 358 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 101 | 0.110 |
Why?
|
| Drug Resistance | 2 | 2012 | 153 | 0.100 |
Why?
|
| Medicaid | 1 | 2018 | 462 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2023 | 5965 | 0.100 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2012 | 11 | 0.100 |
Why?
|
| Child | 9 | 2023 | 22657 | 0.090 |
Why?
|
| Young Adult | 7 | 2020 | 14126 | 0.090 |
Why?
|
| Complement Activation | 1 | 2015 | 411 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2012 | 11799 | 0.090 |
Why?
|
| Esophagoscopy | 2 | 2024 | 221 | 0.090 |
Why?
|
| Adolescent | 8 | 2020 | 22453 | 0.080 |
Why?
|
| Pulse Therapy, Drug | 1 | 2010 | 7 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2023 | 2920 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 405 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 529 | 0.080 |
Why?
|
| Female | 12 | 2025 | 78376 | 0.080 |
Why?
|
| Humans | 17 | 2025 | 144957 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 1721 | 0.070 |
Why?
|
| Male | 11 | 2025 | 72406 | 0.070 |
Why?
|
| Patient Selection | 1 | 2012 | 719 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2010 | 1003 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2010 | 848 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 2947 | 0.060 |
Why?
|
| Remission Induction | 2 | 2020 | 308 | 0.060 |
Why?
|
| Creatinine | 2 | 2020 | 506 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1496 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2011 | 1769 | 0.050 |
Why?
|
| Adult | 6 | 2015 | 40506 | 0.050 |
Why?
|
| Research Design | 1 | 2010 | 1137 | 0.050 |
Why?
|
| Hernia, Hiatal | 1 | 2024 | 41 | 0.050 |
Why?
|
| Aged | 4 | 2025 | 25947 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 1325 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 157 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 7183 | 0.050 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2022 | 8 | 0.050 |
Why?
|
| United States | 4 | 2018 | 15988 | 0.050 |
Why?
|
| Esophagus | 1 | 2024 | 261 | 0.040 |
Why?
|
| Middle Aged | 4 | 2025 | 35928 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5417 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 489 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2023 | 783 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2020 | 16 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 1135 | 0.040 |
Why?
|
| Disease Progression | 2 | 2020 | 2852 | 0.040 |
Why?
|
| Partnership Practice | 1 | 2018 | 3 | 0.030 |
Why?
|
| Cost Control | 1 | 2018 | 37 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 6053 | 0.030 |
Why?
|
| Mortality | 1 | 2020 | 376 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2018 | 103 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2018 | 110 | 0.030 |
Why?
|
| Medicine | 1 | 2018 | 125 | 0.030 |
Why?
|
| Complement C5b | 1 | 2015 | 5 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2925 | 0.030 |
Why?
|
| Apolipoprotein L1 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 548 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2015 | 3676 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 530 | 0.030 |
Why?
|
| Hypoalbuminemia | 1 | 2012 | 28 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2018 | 693 | 0.020 |
Why?
|
| Health Planning | 1 | 2012 | 48 | 0.020 |
Why?
|
| Research Report | 1 | 2012 | 87 | 0.020 |
Why?
|
| Geography | 1 | 2012 | 203 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4293 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 8279 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 518 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 417 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 966 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 2092 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1835 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 479 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 1099 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2018 | 1734 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2118 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2609 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 3335 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 17101 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 4275 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 10792 | 0.010 |
Why?
|